Longaeva Partners »

Pyxis Oncology shares owned by Longaeva Partners

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $735k 503k 1.46

More positions owned by Longaeva Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation Call Option (BSX)
Bank of America Corporation (BAC)
NVIDIA Corporation Call Option (NVDA)
PNC Financial Services (PNC)
Key (KEY)
Goldman Sachs (GS)
Morgan Stanley Com New (MS)
Minimed Group
Citizens Financial (CFG)
Evercore Class A (EVR)
Mastercard Incorporated Cl A (MA)
Msci (MSCI)
S&p Global (SPGI)
Us Bancorp Com New (USB)

View all positions for Longaeva Partners

Top funds holding Pyxis Oncology

Pfizer
Laurion Capital Management
Vanguard Group
Vanguard Capital Management
Palo Alto Investors
683 Capital Management
BlackRock
Renaissance Technologies
Geode Capital Management
Longaeva Partners
Jacobs Levy Equity Management
Millennium Management
Marshall Wace
Jane Street
Decheng Capital

View all funds holding Pyxis Oncology